Clinical trial
Daptomycin in Treating Neutropenia and Fever in Patients With Cancer
NCT00335478 · OHSU Knight Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00335478 |
|---|---|
| Title | Daptomycin in Treating Neutropenia and Fever in Patients With Cancer |
| Official title | Phase II Open Label Pilot Trial of Empiric Daptomycin Treatment for Oncology Patients With Neutropenic Fever |
| Lead sponsor | OHSU Knight Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Fever, Sweating, Hot Flashes, Infection, Neutropenia, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | Daptomycin |
| Enrollment | 54 |
| Start date | Dec 1, 2006 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Jun 12, 2006 |
| Last update posted | May 9, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: